[Results of treatment of atypical endometrial hyperplasia].
Tabakman
Iu Iu
IuIu
Al-Khalabi
A
A
Vasil'eva
I A
IA
D000077713:17 alpha-Hydroxyprogesterone Caproate; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D004714:Endometrial Hyperplasia / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D005040:Ethynodiol Diacetate / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D008656:Mestranol / Q000627:therapeutic use; D009641:Norethynodrel / Q000627:therapeutic use
D003277:Contraceptives, Oral, Combined; D006908:Hydroxyprogesterones; D000077713:17 alpha-Hydroxyprogesterone Caproate; D005040:Ethynodiol Diacetate; C008124:Infecundin; C018467:Bisecurin I; D009641:Norethynodrel; D008656:Mestranol
Rezultaty lecheniia atipicheskoĭ giperplazii éndometriia.